Form 8-K - Current report:
SEC Accession No. 0001558370-23-000715
Filing Date
2023-01-31
Accepted
2023-01-31 08:00:11
Documents
13
Period of Report
2023-01-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230126x8k.htm   iXBRL 8-K 48123
2 EX-99.1 tmb-20230126xex99d1.htm EX-99.1 6630
  Complete submission text file 0001558370-23-000715.txt   176828

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20230126.xsd EX-101.SCH 3108
4 EX-101.LAB tmb-20230126_lab.xml EX-101.LAB 15267
5 EX-101.PRE tmb-20230126_pre.xml EX-101.PRE 10905
7 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230126x8k_htm.xml XML 4646
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 23570261
SIC: 2836 Biological Products, (No Diagnostic Substances)